Ten-Year Incidence of Sarcopenia in a Population-Based Cohort: Results From the ROAD Study.

AWGS 2019 Sarcopenia cohort study incidence

Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
13 Sep 2024
Historique:
received: 08 05 2024
revised: 09 08 2024
accepted: 11 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

To investigate the prevalence and incidence rates of sarcopenia in Japanese community-dwelling people according to the criteria of the Asian Working Group for Sarcopenia 2019 recommendations, using a large-scale population-based cohort over a 10-year follow-up period. Prospective cohort study. This study was conducted using data from the Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study. In total, 1551 participants (521 men and 1030 women; mean age, 65.8 years) from the second ROAD survey (2008-2-10) were included in this study. The participants from the second survey were followed-up at 4, 7, and 10 years. Skeletal muscle mass, handgrip strength, and walking speed were assessed. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. The incidence of sarcopenia was calculated using the person-year method. Cox proportional hazard model was used to assess risk factors for incident sarcopenia. The prevalence of sarcopenia was 8.1% (8.8% in men and 7.7% in women), and the prevalence of severe sarcopenia was 2.9% (2.7% in men and 3.1% in women). The incidence rates of sarcopenia were 17.8 per 1000 and 14.5 per 1000 person-years in men and women, respectively. Additionally, the incidence rates of severe sarcopenia were 6.4 per 1000 and 4.2 per 1000 person-years in men and women, respectively. The significant risk factors for the incidence of sarcopenia were age (+1 year; hazard ratio [HR], 1.10; 95% CI, 1.08-1.12) and body mass index (-1 kg/m The prevalence and incidence rates of sarcopenia in Japan were clarified in this study.

Identifiants

pubmed: 39284567
pii: S1525-8610(24)00685-6
doi: 10.1016/j.jamda.2024.105263
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105263

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Disclosures The authors declare no conflicts of interest.

Auteurs

Toshiko Iidaka (T)

Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical & Research Center, Faculty of Medicine, University of Tokyo, Tokyo, Japan. Electronic address: iidaka-kgw@umin.ac.jp.

Chiaki Horii (C)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Gaku Tanegashima (G)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Shigeyuki Muraki (S)

Muraki Orthopaedics Clinic, Tokyo, Japan.

Hiroyuki Oka (H)

Division of Musculoskeletal AI System Development, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Hiroshi Kawaguchi (H)

Department of Orthopaedic Surgery, Nadogaya Hospital, Chiba, Japan.

Kozo Nakamura (K)

Towa Hospital, Tokyo, Japan.

Toru Akune (T)

National Rehabilitation Center for Persons with Disabilities, Saitama, Japan.

Sakae Tanaka (S)

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Noriko Yoshimura (N)

Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical & Research Center, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

Classifications MeSH